Related references
Note: Only part of the references are listed.Evaluating the affinity and kinetics of small molecule glycomimetics for human and mouse galectin-3 using surface plasmon resonance
Henry Kim et al.
SLAS DISCOVERY (2023)
Multisite Model of Allosterism for the Adenosine A1 Receptor
Giuseppe Deganutti et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2021)
Positive allosteric mechanisms of adenosine A1 receptor-mediated analgesia
Christopher J. Draper-Joyce et al.
NATURE (2021)
Adipose Tissue-Liver Cross Talk in the Control of Whole-Body Metabolism: Implications in Nonalcoholic Fatty Liver Disease
Vian Azzu et al.
GASTROENTEROLOGY (2020)
Long residence time adenosine A1 receptor agonists produce sustained wash- resistant antilipolytic effect in rat adipocytes
Yi Yun et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome
C. Ronald Kahn et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Contribution of adipogenesis to healthy adipose tissue expansion in obesity
Lavanya Vishvanath et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
New paradigms in adenosine receptor pharmacology: allostery, oligomerization and biased agonism
Elizabeth A. Vecchio et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Kinetic Aspects of the Interaction between Ligand and G Protein-Coupled Receptor: The Case of the Adenosine Receptors
Dong Guo et al.
CHEMICAL REVIEWS (2017)
Molecular implications of adenosine in obesity
Fabian Pardo et al.
MOLECULAR ASPECTS OF MEDICINE (2017)
Pathological overproduction: the bad side of adenosine
Pier Andrea Borea et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
The drug-target residence time model: a 10-year retrospective
Robert A. Copeland
NATURE REVIEWS DRUG DISCOVERY (2016)
Adipocyte lipolysis and insulin resistance
Pauline Morigny et al.
BIOCHIMIE (2016)
Synthesis and biological evaluation of a new series of 2-amino-3-aroyl thiophene derivatives as agonist allosteric modulators of the A1 adenosine receptor. A position-dependent effect study
Romeo Romagnoli et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Adenosine signalling in diabetes mellitus-pathophysiology and therapeutic considerations
Luca Antonioli et al.
NATURE REVIEWS ENDOCRINOLOGY (2015)
Molecular mechanism of allosteric modulation at GPCRs: insight from a binding kinetics study at the human A1 adenosine receptor
Dong Guo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
TRR469, a potent A1 adenosine receptor allosteric modulator, exhibits anti-nociceptive properties in acute and neuropathic pain models in mice
Fabrizio Vincenzi et al.
NEUROPHARMACOLOGY (2014)
Regulation of adipocyte lipolysis
Gema Fruehbeck et al.
NUTRITION RESEARCH REVIEWS (2014)
Separation of on-target efficacy from adverse effects through rational design of a bitopic adenosine receptor agonist
Celine Valant et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
An Allosteric Modulator of the Adenosine A1 Receptor Improves Cardiac Function Following Ischaemia in Murine Isolated Hearts
Anna Butcher et al.
PHARMACEUTICALS (2013)
Synthesis and Characterization of Novel 2-Amino-3-benzoylthiophene Derivatives as Biased Allosteric Agonists and Modulators of the Adenosine A1 Receptor
Celine Valant et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
A1 adenosine receptor allosteric enhancer PD-81723 protects against renal ischemia-reperfusion injury
Sang Won Park et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2012)
Long-lasting target binding and rebinding as mechanisms to prolong in vivo drug action
Georges Vauquelin et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Adenosine Receptors: What We Know and What We are Learning
M. L. Trincavelli et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2010)
Delineating the Mode of Action of Adenosine A1 Receptor Allosteric Modulators
Celine Valant et al.
MOLECULAR PHARMACOLOGY (2010)
Comparison of the antilipolytic effects of an A1 adenosine receptor partial agonist in normal and diabetic rats
A. K. Dhalla et al.
DIABETES OBESITY & METABOLISM (2009)
Antilipolytic activity of a novel partial A1 adenosine receptor agonist devoid of cardiovascular effects:: Comparison with nicotinic acid
Arvinder K. Dhalla et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Kinetic analyses for species differences in P-glycoprotein-mediated drug transport
Miki Katoh et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Hippocampal injury and neurobehavioral deficits are improved by PD 81,723 following hyperglycemic cerebral ischemia
JR Meno et al.
EXPERIMENTAL NEUROLOGY (2003)
Role of adenosine in insulin-stimulated release of leptin from isolated white adipocytes of Wistar rats
JT Cheng et al.
DIABETES (2000)
Share Paper
